Abstract
Rotaviruses are the leading cause of childhood diarrhea. The entry of rotaviruses into the host cell is a complex process that includes several interactions of the outer layer proteins of the virus with different cell surface molecules. The fact that neuraminidase treatment of the cells, or preincubation of the virus with sialic acid-containing compounds decrease the infectivity of some rotavirus strains, suggested that these viruses interact with sialic acid on the cell surface. The infectivity of some other rotavirus strains is not affected by neuraminidase treatment of the cells, and therefore they are considered neuraminidase-resistant. However, the current evidence suggests that even these neuraminidase-resistant strains might interact with sialic acids located in context different from that of the sialic acids used by the neuraminidase-sensitive strains. This review summarizes our current knowledge of the rotavirus-sialic acid interaction, its structural basis, the specificity with which distinct rotavirus isolates interact with sialic acid-containing compounds, and also the potential use of these compounds as therapeutic agents.
Article PDF
Similar content being viewed by others
References
Parashar, U.D., Hummelman, E.G., Bresee, J.S., Miller, M.A., Glass, R.I.: Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9, 565–572 (2003)
Cheever, F.S., Mueller, J.H.: Epidemic diarrheal disease of suckling mice. I. Manifestation, epidemiology, and attempts to transmit the disease. J. Exp. Med. 85, 405–416 (1947)
Adams, W.R., Kraft, L.M.: Epizootic diarrhea of infant mice: identification of the etiologic agent. Science 141, 359–360 (1963)
Mebus, C.A., Underdahl, N.R., Rhodes, M.B., Twiehaus, M.J.: Further studies on neonatal calf diarrhea virus. Proc. Annu. Meet. U. S. Anim. Health Assoc. 73, 97–99 (1969)
Bishop, R.F., Davidson, G.P., Holmes, I.H., Ruck, B.J.: Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet. 1281–1283 (1973)
Parashar, U.D., Holman, R.C., Cummings, K.C., Staggs, N.W., Curns, A.T., Zimmerman, C.M., Kaufman, S.F., Lewis, J.E., Vugia, D.J., Powell, K.E., Glass, R.I.: Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics 106, 1413–1421 (2000)
Prasad, B.V., Burns, J.W., Marietta, E., Estes, M.K., Chiu, W.: Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature 343, 476–479 (1990)
Lopez, S., Arias, C.F.: Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol. 12, 271–278 (2004)
Arias, C.F., Romero, P., Alvarez, V., Lopez, S.: Trypsin activation pathway of rotavirus infectivity. Journal Of Virology 70(9), 5832–5839 (1996)
Espejo, R.T., Lopez, S., Arias, C.: Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J. Virol. 37, 156–160 (1981)
Estes, M.K., Graham, D.Y., Mason, B.B.: Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 39, 879–888 (1981)
Clark, S.M., Roth, J.R., Clark, M.L., Barnett, B.B., Spendlove, R.S.: Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J. Virol. 39, 816–822 (1981)
Kaljot, K.T., Shaw, R.D., Rubin, D.H., Greenberg, H.B.: Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J. Virol. 62, 1136–1144 (1988)
Mossel, E.C., Ramig, R.F.: A lymphatic mechanism of rotavirus extraintestinal spread in the neonatal mouse. J. Virol. 77, 12352–12356 (2003)
Ciarlet, M., Crawford, S.E., Cheng, E., Blutt, S.E., Rice, D.A., Bergelson, J.M., Estes, M.K.: VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J. Virol. 76, 1109–1123 (2002)
Spence, L., Fauvel, M., Petro, R., Bloch, S.: Haemagglutinin from Rotavirus. Lancet. 2, 1023 (1976)
Inaba, Y., Sato, K., Takahashi, E., Kurogi, H., Satoda, K.: Hemagglutination with Nebraska calf diarrhea virus. Microbiol. Immunol. 21, 531–534 (1977)
Kalica, A.R., James, J.D.Jr., Kapikian, A.Z.: Hemagglutination by simian rotavirus. J. Clin. Microbiol. 7, 314–315 (1978)
Kitaoka, S., Suzuki, H., Numazaki, T., Sato, T., Konno, T., Ebina, T., Ishida, N., Nakagomi, O., Nakagomi, T.: Hemagglutination by human rotavirus strains. J. Med. Virol. 13, 215–222 (1984)
Shinozaki, T., Fujii, R., Sato, K., Takahashi, E., Ito, Y., Inaba, Y.: Haemagglutinin from human reovirus-like agent. Lancet. 1, 877–878 (1978)
Fukudome, K., Yoshie, O., Konno, T.: Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell absorption. Virology 172, 196–205 (1989)
Bastardo, J.W., Holmes, I.H.: Attachment of SA-11 rotavirus to erythrocyte receptors. Infect. Immun. 29, 1134–1140 (1980)
Keljo, D.J., Smith, A.K.: Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells. J. Pediatr. Gastroenterol Nutr. 7, 249–256 (1988)
Mendez, E., Arias, C.F., Lopez, S.: Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J. Virol. 67, 5253–5259 (1993)
Yolken, R.H., Willoughby, R., Wee, S.B., Miskuff, R., Vonderfecht, S.: Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J. Clin. Invest. 79, 148–154 (1987)
Guo, C.T., Nakagomi, O., Mochizuki, M., Ishida, H., Kiso, M., Ohta, Y., Suzuki, T., Miyamoto, D., Hidari, K.I., Suzuki, Y, Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J. Biochem. (Tokyo) 126, 683–688 (1999)
Ciarlet, M., Estes, M.K.: Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J. Gen. Virol. 80, 943–948 (1999)
Ciarlet, M., Ludert, J.E., Iturriza-Gomara, M., Liprandi, F., Gray, J.J., Desselberger, U., Estes, M.K.: Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J. Virol. 76, 4087–4095 (2002)
Fauvel, M., Spence, L., Babiuk, L.A., Petro, R., Bloch, S.: Hemagglutination and hemagglutination-inhibition studies with a strain of Nebraska calf diarrhea virus (bovine rotavirus). Intervirology 9, 95–105 (1978)
Lee, J., Yoo, D., Redmond, M.J., Attah-Poku, S.K., van den Hurk, J.V., Babiuk, L.A.: Characterization of the interaction between VP8 of bovine rotavirus C486 and cellular components on MA-104 cells and erythrocytes. Can. J. Vet. Res. 62, 56–62 (1998)
Spence, L., Fauvel, M., Petro, R., Babiuk, L.A.: Comparison of rotavirus strains by hemagglutination inhibition. Can. J. Microbiol. 24, 353–362 (1978)
Nakagomi, O., Mochizuki, M., Aboudy, Y., Shif, I., Silberstein, I., Nakagomi, T.: Hemagglutination by a human rotavirus isolate as evidence for transmission of animal rotaviruses to humans. J. Clin. Microbiol. 30, 1011–1013 (1992)
Hoshino, Y., Wyatt, R.G., Greenberg, H.B., Kalica, A.R., Flores, J., Kapikian, A.Z.: Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests. Infect. Immun. 41, 169–173 (1983)
Mochizuki, M., Nakagomi, O.: Haemagglutination by rotaviruses in relation to VP4 genotypes. Res. Virol. 146, 371–374 (1995)
Lee, J.B., Youn, S.J., Nakagomi, T., Park, S.Y., Kim, T.J., Song, C.S., Jang, H.K., Kim, B.S., Nakagomi, O.: Isolation, serologic and molecular characterization of the first G3 caprine rotavirus. Arch. Virol. 148, 643–657 (2003)
Ludert, J.E., Feng, N., Yu, J.H., Broome, R.L., Hoshino, Y., Greenberg, H.B.: Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J. Virol. 70, 487–493 (1996)
Hoshino, Y., Sereno, M.M., Midthun, K., Flores, J., Chanock, R.M., Kapikian, A.Z.: Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo. J. Clin. Microbiol. 25, 290–294 (1987)
Hoshino, Y., Wyatt, R.G., Greenberg, H.B., Kalica, A.R., Flores, J., Kapikian, A.Z.: Isolation and characterization of an equine rotavirus. J. Clin. Microbiol. 18, 585–591 (1983)
Fuentes Panana, E.M., Lopez, S., Gorziglia, M., Arias, C.F.: Mapping the hemagglutination domain of rotaviruses. J. Virol. 69, 2629–2632 (1995)
Hoshino, Y., Wyatt, R.G., Greenberg, H.B., Kalica, A.R., Flores, J., Kapikian, A.Z.: Isolation, propagation, and characterization of a second equine rotavirus serotype. Infect. Immun. 41, 1031–1037 (1983)
Sugiyama, M., Goto, K., Uemukai, H., Mori, Y., Ito, N., Minamoto, N.: Attachment and infection to MA104 cells of avian rotaviruses require the presence of sialic acid on the cell surface. J. Vet. Med. Sci. 66, 461–463 (2004)
Greenberg, H.B., Valdesuso, J., van, W.K., Midthun, K., Walsh, M., McAuliffe, V., Wyatt, R.G., Kalica, A.R., Flores, J., Hoshino, Y.: Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J. Virol. 47, 267–275 (1983)
Kalica, A.R., Flores, J., Greenberg, H.B.: Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 125, 194–205 (1983)
Mackow, E.R., Barnett, J.W., Chan, H., Greenberg, H.B.: The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J. Virol. 63, 1661–1668 (1989)
Lizano, M., Lopez, S., Arias, C.F.: The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus. J. Virol. 65, 1383–1391 (1991)
Fiore, L., Greenberg, H.B., Mackow, E.R.: The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181, 553–563 (1991)
Isa, P., Lopez, S., Segovia, L., Arias, C.F.: Functional and structural analysis of the sialic acid-binding domain of rotaviruses. J. Virol. 71(9), 6749–6756 (1997)
Dormitzer, P.R., Sun, Z.Y., Blixt, O., Paulson, J.C., Wagner, G., Harrison, S.C.: Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8∗ core. J. Virol. 76, 10512–10517 (2002)
Dormitzer, P.R., Sun, Z.Y., Wagner, G., Harrison, S.C.: The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. Embo. J. 21, 885–897 (2002)
Delorme, C., Brussow, H., Sidoti, J., Roche, N., Karlsson, K.A., Neeser, J.R., Teneberg, S.: Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 75, 2276–2287 (2001)
Mendez, E., Arias, C.F., Lopez, S.: Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J. Virol. 70, 1218–1222 (1996)
Monnier, N.K., Dormitzer, P.R.: High resolution structural and functional studies of sialic acid binding variants of rotavirus VP8∗. 8th Interl Symp Double-Stranded Viruses, P2.8 (2003)
Willoughby, R.E., Yolken, R.H., Schnaar, R.L.: Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J. Virol. 64, 4830–4835 (1990)
Willoughby, R.E.: Rotaviruses preferentially bind O-linked sialylglycoconjugates and sialomucins. Glycobiology 3, 437–445 (1993)
Srnka, C.A., Tiemeyer, M., Gilbert, J.H., Moreland, M., Schweingruber, H., de, L.B., James, P.G., Gant, T., Willoughby, R.E., Yolken, RH, et al.: Cell surface ligands for rotavirus: mouse intestinal glycolipids and synthetic carbohydrate analogs. Virology 190, 794–805 (1992)
Rolsma, M.D., Kuhlenschmidt, T.B., Gelberg, H.B., Kuhlenschmidt, M.S.: Structure and function of a ganglioside receptor for porcine rotavirus. J. Virol. 72, 9079–9091 (1998)
Superti, F., Donelli, G.: Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells. J. Gen. Virol. (1991)
Rolsma, M.D., Gelberg, HB., Kuhlenschmidt, M.S.: Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. J. Virol. 68, 258–268 (1994)
Colarow, L., Turini, M., Teneberg, S., Berger, A.: Characterization and biological activity of gangliosides in buffalo milk. Biochim. Biophys. Acta. 1631, 94–106 (2003)
Guerrero, C.A., Zarate, S., Corkidi, G., Lopez, S., Arias, C.F.: Biochemical characterization of rotavirus receptors in MA104 cells. J. Virol. 74, 9362–9371 (2000)
Jolly, C.L., Beisner, B.M., Ozser, E., Holmes, I.H.: Non-lytic extraction and characterisation of receptors for multiple strains of rotavirus. Arch. Virol. 146, 1307–1323 (2001)
Elbein, A.D.: Inhibitors of glycoprotein synthesis. Methods Enzymol. 98, 135–154 (1983)
Pan, Y.T., Elbein, A.D.: How can N-linked glycosylation and processing inhibitors be used to study carbohydrate synthesis and function. In: Glycoproteins edited by Montreuil J, Vliegenthart JFG, Schachter H (Elsevier, Amsterdam, 1995), pp. 415–454.
Roberts, L.: Vaccines. Rotavirus vaccines' second chance. Science 305, 1890–1893 (2004)
Chen, C.C., Baylor, M., Bass, D.M.: Murine intestinal mucins inhibit rotavirus infection. Gastroenterology 105, 84–92 (1993)
Willoughby, R.E., Yolken, R.H.: SA11 rotavirus is specifically inhibited by an acetylated sialic acid. J. Infect. Dis. 161, 116–119 (1990)
Yolken, R.H., Ojeh, C., Khatri, I.A., Sajjan U, Forstner, J.F.: Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J. Infect. Dis. 169, 1002–1006 (1994)
Yolken, R.H., Peterson, J.A., Vonderfecht, S.L., Fouts, E.T., Midthun, K., Newburg, D.S.: Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Invest. 90, 1984–1991 (1992)
Reading, P.C., Holmskov, U., Anders, E.M.: Antiviral activity of bovine collectins against rotaviruses. Journal Of General Virology 79(9), 2255–2263 (1998)
Superti, F., Siciliano, R., Rega, B., Giansanti, F., Valenti, P., Antonini, G.: Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim. Biophys. Acta. 1528, 107–115 (2001)
Kvistgaard, A.S., Pallesen, L.T., Arias, C.F., Lopez, S., Petersen, T.E.: Heegaard CW, and Rasmussen JT, Inhibitory effects of human and bovine milk constituents on rotavirus infections. J. Dairy. Sci. 87, 4088–96 (2004)
Kiefel, M.J., Beisner, B., Bennett, S., Holmes, I.D., vonItzstein, M.: Synthesis and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors. J. Med. Chem. 39 (6), 1314–1320 (1996)
Fazli, A., Bradley, S.J., Kiefel, M.J., Jolly, C., Holmes, I.H., von Itzstein, M.: Synthesis and biological evaluation of sialylmimetics as rotavirus inhibitors. J. Med. Chem. 44, 3292–3301 (2001)
Koketsu, M., Nitoda, T., Sugino, H., Juneja, L.R., Kim, M., Yamamoto, T., Abe, N., Kajimoto, T., Wong, C.H.: Synthesis of a novel sialic acid derivative (sialylphospholipid) as an antirotaviral agent. J. Med. Chem. 40(21), 3332–3335 (1997)
Takahashi, K., Ohashi, K., Abe, Y., Mori, S., Taniguchi, K., Ebina, T., Nakagomi, O., Terada, M., Shigeta, S.: Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model. Antimicrob. Agents Chemother 46, 420–424 (2002)
Urashima. T., Saito, T., Nakamura, T., Messer, M.: Oligosaccharides of milk and colostrum in non-human mammals. Glycoconj J. 18, 357–371 (2001)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Isa, P., Arias, C.F. & López, S. Role of sialic acids in rotavirus infection. Glycoconj J 23, 27–37 (2006). https://doi.org/10.1007/s10719-006-5435-y
Issue Date:
DOI: https://doi.org/10.1007/s10719-006-5435-y